- Home
- NOTV vs ORBS Comparison
NOTV vs ORBS Comparison
Compare NOTV & ORBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NOTV
- ORBS
- Stock Information
- Founded
- NOTV 1974
- ORBS 1966
- Country
- NOTV United States
- ORBS United States
- Employees
- NOTV N/A
- ORBS N/A
- Industry
- NOTV Biotechnology: Pharmaceutical Preparations
- ORBS
- Sector
- NOTV Health Care
- ORBS
- Exchange
- NOTV Nasdaq
- ORBS Nasdaq
- Market Cap
- NOTV 46.7M
- ORBS 47.6M
- IPO Year
- NOTV 1997
- ORBS N/A
- Fundamental
- Price
- NOTV $1.39
- ORBS $11.31
- Analyst Decision
- NOTV Strong Buy
- ORBS
- Analyst Count
- NOTV 1
- ORBS 0
- Target Price
- NOTV $5.00
- ORBS N/A
- AVG Volume (30 Days)
- NOTV 446.2K
- ORBS 4.5M
- Earning Date
- NOTV 08-06-2025
- ORBS 11-13-2025
- Dividend Yield
- NOTV N/A
- ORBS N/A
- EPS Growth
- NOTV N/A
- ORBS N/A
- EPS
- NOTV N/A
- ORBS N/A
- Revenue
- NOTV $505,299,000.00
- ORBS $43,871,615.00
- Revenue This Year
- NOTV $5.64
- ORBS N/A
- Revenue Next Year
- NOTV $5.16
- ORBS N/A
- P/E Ratio
- NOTV N/A
- ORBS N/A
- Revenue Growth
- NOTV 0.85
- ORBS N/A
- 52 Week Low
- NOTV $1.15
- ORBS $0.98
- 52 Week High
- NOTV $6.48
- ORBS $83.12
- Technical
- Relative Strength Index (RSI)
- NOTV 42.19
- ORBS N/A
- Support Level
- NOTV $1.41
- ORBS N/A
- Resistance Level
- NOTV $1.57
- ORBS N/A
- Average True Range (ATR)
- NOTV 0.12
- ORBS 0.00
- MACD
- NOTV 0.02
- ORBS 0.00
- Stochastic Oscillator
- NOTV 31.19
- ORBS 0.00
About NOTV Inotiv Inc.
Inotiv Inc is a pharmaceutical development company specializing in nonclinical and analytical drug discovery, development services to the pharmaceutical, chemical, and medical device industries. It operates in two segments; Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). Through the DSA segment, the company supports the discovery, nonclinical development, and clinical development needs of researchers and clinicians for small molecule drug candidates, biotherapeutics, and biomedical devices. Through the RMS segment, the company offers access to a wide range of small and large research models for basic research, drug discovery, development, and specialized models for specific diseases and therapeutic areas. The company earns maximum revenue from RMS Segment.